Lung Cancer in the Era of COVID-19
Designed to offer expert opinion exchange and provide some practical approaches for management of lung cancer during the COVID-19 pandemic.
Related Articles
ESMO Welcomes the Adoption of a Research Friendly European Health Data Space (EHDS) Regulation by the European Parliament’s Plenary
The EHDS can contribute to boosting cancer research by facilitating the (re)use of existing data sources – in anonymised or pseudorandomised format
Antibody-drug conjugates in lung and breast cancer: Current evidence and future directions – a position statement from the ETOP IBCSG Partners Foundation
Following the approval of the first antibody-drug conjugates (ADCs) in the early 2000s, development has increased dramatically, with 14 ADCs now approved and >100 in…
ESMO Courses in Medical Oncology for Medical Students
The Medical Oncology Course for Students will take place in Naples and Valencia in 2019
Real World Data and Digital Oncology – Digital Health as Cancer C
This ESMO Webinar Series is available to all healthcare professionals working in Oncology.
Editor-in-Chief Of ESMO Rare Cancers, a New, Online, Open Access Journal from ESMO
ESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe.
Editor-in-Chief Of ESMO Rare Cancers, a New, Online, Open Access Journal from ESMO
ESMO is Europe’s leading medical oncology society, providing a professional network for its members and working with national societies across Europe.
YO4YO Virtual Session Series
This live web event series, powered by Young Oncologists for Young Oncologists, consists of highly interactive career and professional development…
Antibody-drug conjugates in lung and breast cancer: Current evidence and future directions – a position statement from the ETOP IBCSG Partners Foundation
Following the approval of the first antibody-drug conjugates (ADCs) in the early 2000s, development has increased dramatically, with 14 ADCs now approved and >100 in…